COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,800 Articles (22,527 medRxiv, 8,273 bioRxiv)

Most recent first Previous |  Page 1869: Articles 18681-18690  | Next

Stable Interaction Of The UK B.1.1.7 lineage SARS-CoV-2 S1 Spike N501Y Mutant With ACE2 Revealed By Molecular Dynamics Simulation
Ahmed, W., Phillip, A. M., Biswas, K. H.
10.1101/2021.01.07.425307 — Posted: 2021-01-07
Neuropilin-1 Assists SARS-CoV-2 Infection by Stimulating the Separation of Spike Protein Domains S1 and S2
Li, Z., Buck, M.
10.1101/2021.01.06.425627 — Posted: 2021-01-07
Comprehensive comparison of transcriptomes in SARS-CoV-2 infection: alternative entry routes and innate immune responses
Cao, Y., Hoffmann, D., Hao, P., Xu, X., Song, L., Kitanovski, S., Wang, J.
10.1101/2021.01.07.425716 — Posted: 2021-01-07
Molecular dynamics simulations and functional studies reveal that hBD-2 binds SARS-CoV-2 spike RBD and blocks viral entry into ACE2 expressing cells
Zhang, L., Ghosh, S. K., Basavarajappa, S. C., Muller-Greven, J., Penfield, J., Brewer, A., Ramakrishnan, P., Buck, M., Weinberg, A.
10.1101/2021.01.07.425621 — Posted: 2021-01-07
Genetic Characteristics and Phylogeny of 969-bp S Gene Sequence of SARS-CoV-2 from Hawaii Reveals the Worldwide Emerging P681H Mutation
Maison, D. P., Ching, L. L., Shikuma, C. M., Nerurkar, V. R.
10.1101/2021.01.06.425497 — Posted: 2021-01-07 Discussion: Onsite
CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge
Lien, C.-E., Lin, Y.-J., Kuo, T.-Y., Campbell, J. D., Traquina, P., Lin, M.-Y., Liu, L. T. C., Chuang, Y.-S., Ku, H.-Y., Liao, C.-C., Chen, Y.-H., Jan, J.-T., Sun, C.-P., Lin, Y.-S., Wu, P.-Y., Wang, Y.-C., Tao, M.-H., Lin, Y.-L.
10.1101/2021.01.07.425674 — Posted: 2021-01-07
New targets for drug design: Importance of nsp14/nsp10 complex formation for the 3'-5' exoribonucleolytic activity on SARS-CoV-2
Saramago, M., Barria, C., Costa, V., Souza, C. S., Viegas, S. C., Domingues, S., Lousa, D., Soares, C. M., Arraiano, C. M., Matos, R. G.
10.1101/2021.01.07.425745 — Posted: 2021-01-07
Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in hamsters
Brustolin, M., Rodon, J., Rodriguez de la Concepcion, M. L., Avila-Nieto, C., Cantero, G., Perez, M., Nigeer, T., Noguera-Julian, M., Guallar, V., Valencia, A., Roca, N., Izquierdo-Useros, N., Blanco, J., Clotet, B., Bensaid, A., Carrillo, J., Vergara-Alert, J., Segales, J.
10.1101/2021.01.07.425729 — Posted: 2021-01-07
Incidence and Characteristics of Co-infection and Secondary Infection in Patients with COVID-19
Guo, Y., Qu, J., Cheng, L., Li, X., Liu, N., Li, T., Jiang, Y., Wan, Q., Zhuo, C., Xiao, S., Liu, B., Chen, Y., Fu, l., Chen, Z., Ma, M., Zhuo, C., Zhong, N.
10.1101/2021.01.06.425542 — Posted: 2021-01-06
Complex Systems Analysis Informs on the Spread of COVID-19
Wang, X., Washington, D., Weber, G. F.
10.1101/2021.01.06.425544 — Posted: 2021-01-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).